SKI Market

Indian Indices

Sensex

79,116.19 -1,122.66
( -1.40%)

Global Indices

Nasdaq

48,766.17 243.89
(0.50%)

Dow Jones

6,891.51 53.88
(0.79%)

Hang Seng

54,115.64 -2,163.41
(-3.84%)

Nikkei 225

10,568.52 84.39
(0.80%)

Forex

USD-INR

91.48 0.43
(0.47%)

EUR-INR

107.28 -0.27
(-0.25%)

GBP-INR

122.62 -0.09
(-0.07%)

JPY-INR

0.58 0.00
(-0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.14

106033.33

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.22

Back

hindustan unilever ltd

Ashok Leyland Feb sales volumes jump 24%

Mar 02,2026

Ashok Leyland sold 22,157 units in month of February 2026 compared to 17,903 units in February 2025, recording a growth of 24%. Total sales include domestic sales of 20,314 units (up 28% YoY).

The company's M&HCV sales stood at 14,755 units (up 28% YoY) while LCV sales were 7,402 units (up 15% YoY) in the month of February 2026.

79,116.19 -1,122.66 ( -1.40%)

48,766.17 243.89 (0.50%)

6,891.51 53.88 (0.79%)

54,115.64 -2,163.41 (-3.84%)

10,568.52 84.39 (0.80%)

91.48 0.43 (0.47%)

107.28 -0.27 (-0.25%)

122.62 -0.09 (-0.07%)

0.58 0.00 (-0.14%)